Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Totipotent Capital is a venture capital firm founded in 2022, based in the United States. The firm focuses on early growth-stage investments in the healthcare sector, particularly in digital health and health technology. Totipotent Capital aims to support companies that are innovating healthcare services and solutions, with a strong emphasis on management teams that possess industry expertise and market awareness.
As of now, Totipotent Capital manages a portfolio of 11 companies, reflecting its commitment to fostering innovation in healthcare. The firm is structured to provide not only capital but also strategic guidance to its portfolio companies, enhancing their ability to navigate the complex healthcare landscape. The team at Totipotent Capital combines experience in healthcare services, regulatory awareness, and clinical credibility, which positions them well to support their investments.
Located in Arlington, Virginia, Totipotent Capital is actively engaged in the healthcare innovation community, maintaining a structured approach to pitch submissions and investment opportunities. The firm’s focus on early-stage ventures aligns with its mission to transform healthcare delivery and access.
Totipotent Capital primarily invests in healthcare services, providers, and founders/operators. The firm targets early growth-stage companies, particularly in Series A and B funding rounds, with a specific focus on digital health and health technology. Their investment strategy emphasizes the importance of management teams that possess a mature understanding of their business needs and the healthcare landscape.
The firm seeks to partner with companies that are innovating in healthcare access, procurement, and disease management. Totipotent Capital looks for ventures that improve healthcare delivery and enhance patient outcomes. The firm’s investment criteria include a strong emphasis on experienced management teams and clear industry expertise, ensuring that the companies they support are well-positioned to succeed in a competitive market.
Geographically, Totipotent Capital focuses on the United States, aligning its investments with the evolving healthcare landscape in the country. The firm typically invests in the range of $25,000 to $150,000, although specific check sizes may vary based on the opportunity and the stage of the company.
Totipotent Capital's portfolio includes a diverse range of companies that are innovating in the healthcare sector. Notable portfolio companies include:
This portfolio reflects Totipotent Capital's commitment to supporting innovative solutions that enhance healthcare delivery and patient care.
Shana Lawlor, Managing Partner — Shana has a background as an LP in Rock Health Capital and has invested in Health Tech Capital. She has served as Board President of Health Tech-X and has experience as a digital health entrepreneur and consultant. Her previous roles include positions at Booz Allen Hamilton, Arthur Andersen, and PwC.
Dale C. Van Demark, Co-Founder and Partner — Dale is a health practice lawyer at McDermott Will & Emery, focusing on strategic transactions and digital health matters. He is also an LP in Rock Health Capital and has invested in Health Tech Capital.
Adam R. Marks, Partner — Adam is a health practice lawyer at Sheppard Mullin, representing hospitals, health systems, providers, and investors in transactions including M&A, affiliations, and joint ventures. He is an LP in Rock Health Capital and has invested in Health Tech Capital.
Dr. Gopal Bajaj, Partner — Dr. Bajaj is the President of Radiation Oncology Associates, PC, and has served as the emeritus Chairman and Medical Director for Advanced Radiation Oncology and Proton Therapy at Inova Schar Cancer Institute. He is also an LP in Rock Health Capital and has invested in Health Tech Capital.
To pitch to Totipotent Capital, founders should submit their company summaries through the firm's website. The submission deadline is each Tuesday by close of business. The firm conducts weekly reviews of submissions and holds bi-monthly pitch meetings.
Founders should include a clear overview of their business model, market opportunity, and management team's expertise in their pitch deck. A well-structured presentation that aligns with the firm's focus on healthcare innovation will increase the chances of engagement.
For any inquiries or additional information, interested parties can reach out via email at info@totipotent.vc.
As of April 2026, Totipotent Capital continues to engage actively with the healthcare innovation community, showcasing updates on their portfolio companies and ongoing investment activities. The firm maintains a structured approach to pitch submissions, indicating a consistent flow of potential investment opportunities.
Recent portfolio updates highlight the progress of companies like Embr Labs and Biorithm, which are making strides in their respective markets. Totipotent Capital's commitment to supporting healthcare innovations is evident through its ongoing investments and strategic partnerships.
What are Totipotent Capital's investment criteria?
Totipotent Capital primarily invests in early growth-stage healthcare companies, particularly in Series A and B funding rounds. The firm emphasizes the importance of management teams with industry expertise and a mature understanding of their business needs.
How can I pitch to Totipotent Capital?
Interested parties can submit their company summaries through the Totipotent Capital website. The submission window closes each Tuesday by close of business. The firm reviews submissions weekly and holds bi-monthly pitch meetings.
What makes Totipotent Capital different from other investors?
Totipotent Capital focuses specifically on healthcare innovations and partners with management teams that have a deep understanding of the healthcare landscape. Their expertise in regulatory awareness and clinical credibility adds significant value to their portfolio companies.
What is the geographic focus of Totipotent Capital?
The firm primarily invests in companies based in the United States, aligning its investments with the evolving healthcare landscape in the country.
What is the typical check size for investments?
Totipotent Capital typically invests in the range of $25,000 to $150,000, although specific check sizes may vary based on the opportunity and the stage of the company.
What kind of support does Totipotent Capital provide to its portfolio companies?
Totipotent Capital adds value through its team's expertise in healthcare services, regulatory awareness, and clinical credibility. The firm supports founders with go-to-market strategies that align with current health policy trends.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.